ProCE Banner Activity

BANNER Study: Broadly Neutralizing Antibody VH3810109 in People With HIV Naive to Treatment

Slideset Download
Conference Coverage

The broadly neutralizing antibody VH3810109, administered by a single IV infusion, displayed antiviral efficacy and was well tolerated in people with HIV naive to treatment.

Released: November 04, 2022


Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare